ORKA

Oruka Therapeutics, Inc. Common Stock
ORKA
Market cap $996M

28.46 USD

+0.95

3.45%

At close Oct 9, 4:00 PM EDT

1 day

3.45%

5 days

16.69%

1 month

1.64%

3 months

1.68%

6 months

1.68%

Year to date

1.68%

1 year

1.68%

5 years

1.68%

About: Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.

Healthcare In Vitro & In Vivo Diagnostic Substances

–

Funds holding %

of 6,740 funds

Analysts bullish %

of 6 analysts

Fund manager confidence

See Fund Rankings

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$40

41%

upside

Avg. target

$42

49%

upside

High target

$45

58%

upside

6 analyst ratings

6 positive

100%

0 neutral

0 negative

HC Wainwright & Co. Mitchell Kapoor 48% 1-year accuracy 30 / 63 met price target	58%upside $45	Buy Initiated	7 Oct 2024
Leerink Partners David Risinger 60% 1-year accuracy 3 / 5 met price target	55%upside $44	Outperform Initiated	17 Sept 2024
Leerink Swann David Risinger 60% 1-year accuracy 3 / 5 met price target	55%upside $44	Outperform Initiated	17 Sept 2024
LifeSci Capital	44%upside $41	Outperform Initiated	16 Sept 2024
Jefferies Michael Yee 40% 1-year accuracy 4 / 10 met price target	41%upside $40	Buy Initiated	13 Sept 2024